Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease-Reference-Cited by-同舟云学术

Therapeutic advantage of angiotensin-converting enzyme inhibitors in patients with proteinuric chronic kidney disease

Published:2010-05 Issue:3 Volume:25 Page:203-208
ISSN:0910-8327
Container-title:Heart and Vessels
language:en
Short-container-title:Heart Vessels

Author:

Omae Kiyotsugu,Ogawa Tetsuya,Nitta Kosaku

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00380-009-1188-4.pdf

Reference42 articles.

1. Liu H, Yu J, Chen F, Li J, Hu D (2007) Inpatients with coronary heart disease have a high prevalence of chronic kidney disease based on estimated glomerular filtration rate (eGFR) in China. Heart Vessels 22:223–228

2. Norris K, Vaughn C (2003) The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther 1:51–63

3. Vogt L, Kocks MJ, Navis G (2004) Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and nondiabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Minerva Med 95:395–409

4. Ruggenenti P (2004) Angiotensin-converting enzyme inhibition and angiotensin II antagonism in nondiabetic chronic nephropathies. Semin Nephrol 24:158–167

5. Noda M, Fukuda R, Matsuo T (1997) Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats. Kidney Int 63(suppl):S136–S139

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Chronic Kidney Disease Progression Influenced by the Type of Renin-Angiotensin-System Blocker Used?;Nephron;2019

2. Effect of calcium channels blockers and inhibitors of the renin-angiotensin system on renal outcomes and mortality in patients suffering from chronic kidney disease: systematic review and meta-analysis;Renal Failure;2016-04-07

3. Cost-effectiveness of Primary Screening for CKD: A Systematic Review;American Journal of Kidney Diseases;2014-05

4. Losartan preserves glomerular basement membrane anionic charge sites in a rat model of nephropathy;Journal of Nephrology;2012-10-10

5. Efficacy analysis of the renoprotective effects of aliskiren in hypertensive patients with chronic kidney disease;Heart and Vessels;2012-05-23